Clinical Immunology · Agammaglobulinemia 7

Recognizing Symptoms and Knowing When to Act

At a Glance

In Agammaglobulinemia 7, children may develop repeated or severe infections after maternal antibodies fade at 6 to 12 months. Pneumonia, breathing trouble, diarrhea, dehydration, or neurologic changes need prompt attention, with severe signs requiring emergency care.

Because Agammaglobulinemia 7 (AGM7) leaves your child without the antibody “memory” needed to fight off certain germs, infections often look different and happen more frequently than they do in other children ^[1]. Recognizing these patterns and knowing when to seek medical care are the most important tools you have for protecting your child’s health ^[2].

The Timing of Symptoms

Most infants with AGM7 appear healthy at birth because they are protected by antibodies passed from their mother during pregnancy ^[3]. However, this temporary protection begins to fade between 6 and 12 months of age ^[4]. This is usually when the first signs of the condition—recurrent or unusually severe infections—begin to appear ^[5].

Common Infection Patterns

Because AGM7 is so rare, much of what we know about symptom frequency comes from larger cohorts of children with similar primary antibody deficiencies. In these similar conditions, normal childhood illnesses often behave differently. You may notice:

Recurrent Respiratory Infections: Pneumonia (lung infection) is a major feature, affecting over 60% of children in cohorts with similar conditions ^[6]. Your child may also experience frequent sinusitis or otitis media (ear infections) that keep coming back even after a full course of antibiotics ^[7]^[8].
Chronic Wet Cough: A lingering cough that produces mucus (a wet cough) is reported in about 90% of children with similar immunodeficiencies before they start treatment ^[7].
Gastrointestinal Issues: Diarrhea is common and may be caused by bacteria like Campylobacter or parasites like Giardia ^[8]^[9]. If left untreated, chronic diarrhea can lead to poor weight gain.
Skin and Joint Issues: Unusual skin sores or painful, swollen joints are uncommon but potentially urgent findings that require prompt evaluation ^[10].

The Importance of Early Treatment

If the profound antibody deficiency caused by AGM7 is not treated, the cycle of repeated infections can lead to permanent health problems. The most significant risk is bronchiectasis, a condition where the airways in the lungs become permanently scarred and thickened due to repeated bouts of pneumonia ^[8]^[11]. Starting therapy early is the best way to prevent this damage and reduce hospitalizations ^[12].

Red Flags: When to Seek Emergency Care

Because your child lacks natural antibodies, infections can move from “mild” to “life-threatening” quickly. However, it is vital to follow an individualized, age-specific written sick-day plan created by your immunologist.

General warning signs that typically require immediate Emergency Room evaluation include:

Fever in a Young Infant: A rectal temperature of 100.4°F (38.0°C) or higher in an infant under 3 months generally requires urgent medical assessment for suspected sepsis ^[13]. For older children, follow the specific fever thresholds provided by your doctor.
Neurologic Changes: Extreme sleepiness (lethargy), difficulty waking up, a bulging soft spot (fontanelle) on the head, or a stiff neck ^[14]^[15].
Respiratory Distress: Breathing that is much faster than normal, skin pulling in between the ribs or at the neck (retractions), or a bluish tint to the lips or fingernails ^[16].
Severe Dehydration: Persistent vomiting or diarrhea where the child cannot keep fluids down, has dry lips, or stops producing wet diapers ^[17].

When You Arrive at the ER:
Always inform emergency responders and ER staff that your child has Agammaglobulinemia 7 and lacks B cells and antibodies. Ask them to consult your immunologist immediately. While your child is at higher risk for bacterial infections, do not assume every fever is bacterial. The clinical team will perform a thorough assessment and take cultures (blood, urine, etc.). If they suspect a serious bacterial infection or sepsis, they will start immediate empiric antibiotics while waiting for the culture results ^[18].

Common questions in this guide

At what age do Agammaglobulinemia 7 symptoms usually start?

Many infants with AGM7 seem healthy at birth because maternal antibodies provide temporary protection. As those antibodies fade around 6 to 12 months, recurrent or unusually severe infections may become noticeable.

What infections and symptoms are common in a child with AGM7?

Common patterns include repeated pneumonia, sinus infections, ear infections, and a persistent wet cough. Diarrhea from infections such as Campylobacter or Giardia can also occur and may contribute to poor weight gain.

When should I take my child with AGM7 to the emergency room?

A rectal temperature of 100.4°F (38.0°C) or higher in an infant under 3 months needs urgent medical assessment. At any age, neurologic changes, breathing distress, bluish lips, or severe dehydration are emergency warning signs; follow your immunologist’s age-specific plan for older children’s fever thresholds.

What should emergency staff know if my child has AGM7?

Tell emergency responders and ER staff that your child has Agammaglobulinemia 7 and lacks B cells and antibodies, and ask them to contact the immunologist. The team may obtain blood and urine cultures and start empiric antibiotics if sepsis or a serious bacterial infection is suspected.

Can repeated infections from AGM7 cause permanent lung damage?

Yes. Repeated pneumonia can cause bronchiectasis, in which the airways become scarred and thickened. Early treatment and prompt evaluation of infections can help reduce this risk and hospitalizations.

What is a sick-day plan for a child with AGM7?

A sick-day plan is a written, age-specific plan created with the child’s immunologist that explains which symptoms or temperatures require a call, an urgent visit, or emergency care. It helps caregivers act quickly and know whom to contact when illness begins.

Get notified when new evidence is published on agammaglobulinemia 7, autosomal recessive.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References (18)

1
[Genetic diagnosis of patients with primary agammaglobulinemia treated at third level peruvian centers].
Matos-Benavides E, García-Gomero D, Inocente-Malpartida R, et al.
Revista peruana de medicina experimental y salud publica 2019; (36(4)):664-669 doi:10.17843/rpmesp.2019.364.4311.
PMID: 31967259
2
"It's a Godsend": Parental experiences of genomic testing for paediatric inborn errors of immunity.
Clark A, DeBortoli E, Blancoe M, et al.
European journal of human genetics : EJHG 2025; (33(10)):1342-1349 doi:10.1038/s41431-025-01917-7.
PMID: 40730688
3
Single Mutation Different Clinical Findings: IGLL1 Defect.
Naiboğlu S, Gezdirici A, Ulaş S, et al.
Iranian journal of allergy, asthma, and immunology 2024; (23(4)):452-456 doi:10.18502/ijaai.v23i4.16218.
PMID: 39549297
4
[X-linked agammaglobulinemia: experience in a Portuguese hospital].
Fernandes A, Guedes M, Vasconcelos J, et al.
Anales de pediatria (Barcelona, Spain : 2003) 2015; (82(3)):166-71.
PMID: 25443324
5
Agammaglobulinemia: from X-linked to Autosomal Forms of Disease.
Cardenas-Morales M, Hernandez-Trujillo VP
Clinical reviews in allergy & immunology 2022; (63(1)):22-35 doi:10.1007/s12016-021-08870-5.
PMID: 34241796
6
Evaluation of respiratory complications in patients with X-linked and autosomal recessive agammaglobulinemia.
Fekrvand S, Yazdani R, Olbrich P, et al.
Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 2020; (31(4)):405-417 doi:10.1111/pai.13228.
PMID: 32058651
7
[Intravenous immunoglobulin replacement therapy in 114 cases of congenital agammaglobulinemia].
Li YW, Chen H, Zhang Y, et al.
Zhonghua er ke za zhi = Chinese journal of pediatrics 2021; (59(6)):495-500 doi:10.3760/cma.j.cn112140-20201016-00950.
PMID: 34102824
8
Clinical and Genetic Profile of X-Linked Agammaglobulinemia: A Multicenter Experience From India.
Rawat A, Jindal AK, Suri D, et al.
Frontiers in immunology 2020; (11()):612323 doi:10.3389/fimmu.2020.612323.
PMID: 33584693
9
Gastrointestinal disorders next to respiratory infections as leading symptoms of X-linked agammaglobulinemia in children - 34-year experience of a single center.
Pac M, Bernatowska EA, Kierkuś J, et al.
Archives of medical science : AMS 2017; (13(2)):412-417 doi:10.5114/aoms.2016.60338.
PMID: 28261296
10
Concomitant diagnosis of immune deficiency and Pseudomonas sepsis in a 19 month old with ecthyma gangrenosum by host whole-genome sequencing.
Sanford E, Farnaes L, Batalov S, et al.
Cold Spring Harbor molecular case studies 2018; (4(6)) doi:10.1101/mcs.a003244.
PMID: 30559311
11
X-Linked Agammaglobulinemia: Infection Frequency and Infection-Related Mortality in the USIDNET Registry.
O'Toole D, Groth D, Wright H, et al.
Journal of clinical immunology 2022; (42(4)):827-836 doi:10.1007/s10875-022-01237-1.
PMID: 35288819
12
Self-reported Clinical Outcomes and Quality of Life in Agammaglobulinemia: the Importance of an Early Diagnosis.
Blom M, Duintjer AJ, Jamee M, et al.
Journal of clinical immunology 2025; (45(1)):125.
PMID: 40853601
13
A Registry Study of 240 Patients with X-Linked Agammaglobulinemia Living in the USA.
Hernandez-Trujillo V, Zhou C, Scalchunes C, et al.
Journal of clinical immunology 2023; (43(6)):1468-1477 doi:10.1007/s10875-023-01502-x.
PMID: 37219739
14
Meningoencephalitis in primary antibody deficiency: Our experience from northwest India.
Jindal AK, Chaudhary H, Tyagi R, et al.
Journal of neuroimmunology 2022; (371()):577952 doi:10.1016/j.jneuroim.2022.577952.
PMID: 36030644
15
Streptococcal pneumonia meningitis as an initial presentation of X-linked agammaglobulinemia: A case report and discussion.
Kadden D, Fowler G, Engel E, et al.
Journal of the American College of Emergency Physicians open 2021; (2(5)):e12553 doi:10.1002/emp2.12553.
PMID: 34568871
16
A case report of X-linked agammaglobulinemia complicated with necrotic pneumonia.
Zhang X, Zhu J
Translational pediatrics 2026; (15(4)):160 doi:10.21037/tp-2025-353.
PMID: 42158683
17
Ecthyma gangrenosum due to Pseudomonas aeruginosa sepsis as initial manifestation of X-linked agammaglobulinemia: a case report.
Huang H, Bai K, Fu Y, et al.
BMC pediatrics 2020; (20(1)):540 doi:10.1186/s12887-020-02436-8.
PMID: 33261572
18
Distinct Clinical Features and Novel Mutations in Taiwanese Patients With X-Linked Agammaglobulinemia.
Yeh YH, Hsieh MY, Lee WI, et al.
Frontiers in immunology 2020; (11()):2001 doi:10.3389/fimmu.2020.02001.
PMID: 33013854

This page is for caregivers learning to recognize infections and emergencies in a child with AGM7. It is informational only and does not replace advice from your child’s immunologist or emergency clinicians.